Global Dengue Vaccines Competitive Landscape Professional Research Report 2024

Global Dengue Vaccines Competitive Landscape Professional Research Report 2024



Research Summary

Dengue vaccines are immunizations developed to protect against dengue fever, a viral disease transmitted through the bites of infected mosquitoes, primarily Aedes aegypti and Aedes albopictus. The vaccines are designed to stimulate the immune system to produce antibodies against the dengue virus, preventing or reducing the severity of the infection if a vaccinated person is exposed to the virus. Several dengue vaccines have been developed, including the CYD-TDV vaccine (Dengvaxia), which has been approved for use in some countries. Dengue vaccines are particularly important in regions where dengue is endemic and poses a significant public health threat. However, developing an effective dengue vaccine has been challenging due to the existence of multiple dengue virus serotypes, which require the vaccine to provide protection against all four serotypes. Continued research and efforts are focused on improving dengue vaccines to enhance their safety and efficacy, contributing to global efforts to control and prevent the spread of dengue fever.

According to DIResearch's in-depth investigation and research, the global Dengue Vaccines market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Dengue Vaccines include Sanofi, Takeda etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Dengue Vaccines. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Dengue Vaccines market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Dengue Vaccines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Dengue Vaccines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Dengue Vaccines Include:

Sanofi

Takeda

Dengue Vaccines Product Segment Include:

Dengvaxia

TAK-003

Others

Dengue Vaccines Product Application Include:

Preventive Vaccination in Endemic Regions

Protection for Travelers

Integration into Routine Immunization Programs

Occupational Vaccination

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Dengue Vaccines Industry PESTEL Analysis

Chapter 3: Global Dengue Vaccines Industry Porter’s Five Forces Analysis

Chapter 4: Global Dengue Vaccines Major Regional Market Size and Forecast Analysis

Chapter 5: Global Dengue Vaccines Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Dengue Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Dengue Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Dengue Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Dengue Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Dengue Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Dengue Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Dengue Vaccines Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 Dengue Vaccines Market Overview
1.1 Product Definition and Statistical Scope
1.2 Dengue Vaccines Product by Type
1.2.1 Global Dengue Vaccines Market Size by Type, 2023 VS 2024 VS 2030
1.2.2 Dengvaxia
1.2.3 TAK-003
1.2.4 Others
1.3 Dengue Vaccines Product by Application
1.3.1 Global Dengue Vaccines Market Size by Application, 2023 VS 2024 VS 2030
1.3.2 Preventive Vaccination in Endemic Regions
1.3.3 Protection for Travelers
1.3.4 Integration into Routine Immunization Programs
1.3.5 Occupational Vaccination
1.4 Global Dengue Vaccines Market Revenue Analysis (2019-2030)
1.5 Dengue Vaccines Market Development Status and Trends
1.5.1 Dengue Vaccines Industry Development Status Analysis
1.5.2 Dengue Vaccines Industry Development Trends Analysis
2 Dengue Vaccines Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Dengue Vaccines Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Dengue Vaccines Market Analysis by Regions
4.1 Dengue Vaccines Overall Market: 2023 VS 2024 VS 2030
4.2 Global Dengue Vaccines Revenue and Forecast Analysis (2019-2030)
4.2.1 Global Dengue Vaccines Revenue and Market Share by Region (2019-2024)
4.2.2 Global Dengue Vaccines Revenue Forecast by Region (2025-2030)
5 Global Dengue Vaccines Market Size by Type and Application
5.1 Global Dengue Vaccines Market Size by Type
5.2 Global Dengue Vaccines Market Size by Application
6 North America
6.1 North America Dengue Vaccines Market Size and Growth Rate Analysis (2019-2030)
6.2 North America Key Manufacturers Analysis
6.3 North America Dengue Vaccines Market Size by Type
6.4 North America Dengue Vaccines Market Size by Application
6.5 North America Dengue Vaccines Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Dengue Vaccines Market Size and Growth Rate Analysis (2019-2030)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Dengue Vaccines Market Size by Type
7.4 Europe Dengue Vaccines Market Size by Application
7.5 Europe Dengue Vaccines Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Dengue Vaccines Market Size and Growth Rate Analysis (2019-2030)
8.2 China Key Manufacturers Analysis
8.3 China Dengue Vaccines Market Size by Type
8.4 China Dengue Vaccines Market Size by Application
9 APAC (excl. China)
9.1 APAC (excl. China) Dengue Vaccines Market Size and Growth Rate Analysis (2019-2030)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Dengue Vaccines Market Size by Type
9.4 APAC (excl. China) Dengue Vaccines Market Size by Application
9.5 APAC (excl. China) Dengue Vaccines Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Indonesia
9.5.6 Vietnam
9.5.7 Malaysia
9.5.8 Thailand
10 Latin America
10.1 Latin America Dengue Vaccines Market Size and Growth Rate Analysis (2019-2030)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Dengue Vaccines Market Size by Type
10.4 Latin America Dengue Vaccines Market Size by Application
10.5 Latin America Dengue Vaccines Market Size by Country
10.5.1 Mecixo
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Dengue Vaccines Market Size and Growth Rate Analysis (2019-2030)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Dengue Vaccines Market Size by Type
11.4 Middle East & Africa Dengue Vaccines Market Size by Application
11.5 Middle East & Africa Dengue Vaccines Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Market Competition by Manufacturers
12.1 Global Dengue Vaccines Market Revenue by Key Manufacturers (2020-2024)
12.2 Dengue Vaccines Competitive Landscape Analysis and Market Dynamic
12.2.1 Dengue Vaccines Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Sanofi
13.1.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Sanofi Dengue Vaccines Product Portfolio
13.1.3 Sanofi Dengue Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.2 Takeda
13.2.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Takeda Dengue Vaccines Product Portfolio
13.2.3 Takeda Dengue Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
14 Industry Chain Analysis
14.1 Dengue Vaccines Industry Chain Analysis
14.2 Dengue Vaccines Industry Raw Material and Suppliers Analysis
14.2.1 Upstream Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Dengue Vaccines Typical Downstream Customers
14.4 Dengue Vaccines Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings